CI
CX Institutional’s ResMed RMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
1,535
+5
| +0.3% | +$1.29K | 0.01% | 432 |
|
|
2025
Q1 | $342K | Buy |
1,530
+97
| +7% | +$21.7K | 0.01% | 452 |
|
|
2024
Q4 | $328K | Buy |
1,433
+2
| +0.1% | +$457 | 0.01% | 422 |
|
|
2024
Q3 | $349K | Buy |
1,431
+35
| +3% | +$8.55K | 0.02% | 435 |
|
|
2024
Q2 | $267K | Sell |
1,396
-49
| -3% | -$9.38K | 0.01% | 483 |
|
|
2024
Q1 | $286K | Buy |
1,445
+153
| +12% | +$30.3K | 0.01% | 469 |
|
|
2023
Q4 | $222K | Buy |
+1,292
| New | +$222K | 0.01% | 472 |
|
|
2023
Q2 | – | Sell |
-966
| Closed | -$212K | – | 534 |
|
|
2023
Q1 | $212K | Buy |
+966
| New | +$212K | 0.01% | 467 |
|
|
2022
Q3 | – | Sell |
-664
| Closed | -$139K | – | 997 |
|
|
2022
Q2 | $139K | Buy |
+664
| New | +$139K | 0.01% | 492 |
|
|
2021
Q4 | – | Sell |
-458
| Closed | -$121K | – | 793 |
|
|
2021
Q3 | $121K | Sell |
458
-2
| -0.4% | -$528 | 0.01% | 417 |
|
|
2021
Q2 | $113K | Buy |
460
+125
| +37% | +$30.7K | 0.01% | 423 |
|
|
2021
Q1 | $65K | Buy |
335
+18
| +6% | +$3.49K | 0.01% | 440 |
|
|
2020
Q4 | $67K | Buy |
317
+57
| +22% | +$12K | 0.01% | 403 |
|
|
2020
Q3 | $45K | Buy |
260
+19
| +8% | +$3.29K | ﹤0.01% | 399 |
|
|
2020
Q2 | $46K | Buy |
241
+66
| +38% | +$12.6K | 0.01% | 348 |
|
|
2020
Q1 | $26K | Buy |
175
+18
| +11% | +$2.67K | ﹤0.01% | 351 |
|
|
2019
Q4 | $24K | Hold |
157
| – | – | ﹤0.01% | 335 |
|
|
2019
Q3 | $21K | Buy |
157
+38
| +32% | +$5.08K | ﹤0.01% | 369 |
|
|
2019
Q2 | $15K | Buy |
119
+86
| +261% | +$10.8K | ﹤0.01% | 431 |
|
|
2019
Q1 | $3K | Buy |
33
+27
| +450% | +$2.46K | ﹤0.01% | 646 |
|
|
2018
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 509 |
|